Health · 19 August 2026
Experimental mRNA drug stops skin cancer returning after surgery
Unsplash / Lucas Vasques
Drugmakers Merck and Moderna announced on Wednesday that their personalised mRNA vaccine, intismeran, prevented melanoma from coming back or spreading. The experimental drug was given to over 1,000 patients who had surgery to remove their cancer, combined with another drug called Keytruda. Intismeran is a potentially significant step for people with melanoma, the deadliest form of skin cancer.
Reported by Independent · How we write briefs